Sep 23, 2024, 12:26 PM
Sep 23, 2024, 12:26 PM

Mum, 34, diagnosed with rare cancer after flu-like symptoms in Lancashire

Tragic
Highlights
  • Emma Snape, 34, from Lancashire, was diagnosed with epithelioid hemangioendothelioma (EHE) after experiencing flu-like symptoms.
  • Doctors found multiple nodules in her lungs and omentum, leading to a terminal diagnosis with a low survival rate.
  • Her twin sister Kym has been actively fundraising and researching to support Emma and raise awareness for EHE.
Story

Emma Snape, a 34-year-old woman from Lancashire, initially believed she was suffering from a severe flu in February. However, her symptoms escalated, leading to hospitalization where she was diagnosed with epithelioid hemangioendothelioma (EHE), a rare and aggressive cancer affecting blood vessel cells. This condition is particularly uncommon, impacting one in a million individuals, and is more prevalent in women and younger adults. Upon diagnosis, doctors discovered 20 nodules in Emma's lungs and additional growths in her omentum, indicating a terminal prognosis. EHE is known for its poor survival rates, with only half of those diagnosed living beyond five years. Emma's twin sister, Kym, has been a crucial support during this challenging time, actively researching the disease and organizing fundraising efforts to aid in finding a cure. Kym has established a donation page for the EHE Rare Cancer Charity, emphasizing the importance of funding critical research. She expressed the emotional toll of watching her sister endure this battle, highlighting the helplessness felt in the face of such a devastating diagnosis. Emma has undergone numerous hospital visits and treatments since her diagnosis, reflecting the ongoing struggle against this rare cancer. The community has rallied around Emma, showcasing generosity and support during her ordeal. Kym's commitment to raising awareness and funds for EHE research underscores the urgent need for advancements in treatment options for this rare and aggressive cancer.

Opinions

You've reached the end